Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ternisien

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1991
Effect of phosphopyridoxylation on thrombin interaction with platelet glycoprotein IbC Ternisien, M Jandrot-Perrus, M G Huisse, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Essential thrombocythemia and cerebral ischemic accident: discussion of two cases]C Alecu, P Abraham, C Ternisien, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 30, 2016
Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF<sup>®</sup> -treated patientsC Pouplard, C Ternisien, C Desconclois, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin binding to platelet membrane glycoprotein IbM Jandrot-Perrus, M G Huisse, C Ternisien, et al.
Platelets|November 26, 2016
Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhageO Espitia, C Ternisien, C Agard, et al.
Thrombosis and Haemostasis|March 1, 1995
Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytesC Ternisien, V Ollivier, F Khechai, et al.
International Journal of Laboratory Hematology|May 13, 2014
Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?C Pouplard, C Desconclois, F Sobas, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2007
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopeniaC Pouplard, P Gueret, M Fouassier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosisA Veyradier, C Caron, C Ternisien, et al.
FEBS Letters|November 8, 1993
Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytesM Ramani, V Ollivier, F Khechai, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1991
Effect of phosphopyridoxylation on thrombin interaction with platelet glycoprotein IbC Ternisien, M Jandrot-Perrus, M G Huisse, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Essential thrombocythemia and cerebral ischemic accident: discussion of two cases]C Alecu, P Abraham, C Ternisien, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 30, 2016
Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF<sup>®</sup> -treated patientsC Pouplard, C Ternisien, C Desconclois, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin binding to platelet membrane glycoprotein IbM Jandrot-Perrus, M G Huisse, C Ternisien, et al.
Platelets|November 26, 2016
Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhageO Espitia, C Ternisien, C Agard, et al.
Thrombosis and Haemostasis|March 1, 1995
Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytesC Ternisien, V Ollivier, F Khechai, et al.
International Journal of Laboratory Hematology|May 13, 2014
Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?C Pouplard, C Desconclois, F Sobas, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2007
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopeniaC Pouplard, P Gueret, M Fouassier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosisA Veyradier, C Caron, C Ternisien, et al.
FEBS Letters|November 8, 1993
Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytesM Ramani, V Ollivier, F Khechai, et al.
Pageof 4